Provided by Tiger Trade Technology Pte. Ltd.

CARSGEN-B

14.960
-0.240-1.58%
Volume:4.59M
Turnover:67.60M
Market Cap:8.53B
PE:-74.18
High:15.220
Open:15.220
Low:14.350
Close:15.200
52wk High:25.600
52wk Low:9.900
Shares:570.00M
HK Float Shares:570.00M
Volume Ratio:0.95
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.202
ROE:-11.21%
ROA:-9.61%
PB:9.57
PE(LYR):-74.18
PS:59.65

Loading ...

Assessing CARsgen Therapeutics Holdings’s Valuation After Full Year 2025 Results And Narrowed Net Loss

Simply Wall St.
·
Mar 19

CARsgen Therapeutics Holdings SEHK 2171 Valuation After Stronger 2025 Results And Narrowed Net Loss

Simply Wall St.
·
Mar 12

Stock Track | CARSGEN-B Soars 11.71% Intraday on Robust Annual Results and Stock Connect Inclusion

Stock Track
·
Mar 10

CARSGEN-B Shares Surge Over 12% Following Strong Annual Revenue Growth and Inclusion in Stock Connect

Stock News
·
Mar 10

CARsgen Therapeutics grants 4.27 million share options under post-IPO scheme

Reuters
·
Mar 09

BUZZ-CARsgen Therapeutics jumps most on record as full-year losses narrow

Reuters
·
Mar 09

CARSGEN-B Surges Over 32% Following Earnings Release, Annual Loss Narrows by 87.7%

Deep News
·
Mar 09

CARsgen Therapeutics Shares to Join Stock Connect Programs

MT Newswires Live
·
Mar 09

Stock Track | CARSGEN-B Soars 15.00% Intraday on Inclusion in Stock Connect Southbound Trading

Stock Track
·
Mar 09

CARSGEN-B (02171) Added to Southbound Stock Connect Eligibility List

Stock News
·
Mar 09

CARSGEN-B (02171) Announces Inclusion in Southbound Stock Connect

Bulletin Express
·
Mar 09

CARsgen Therapeutics added to Stock Connect southbound eligible list effective March 9, 2026

Reuters
·
Mar 09

BRIEF-Carsgen Therapeutics Posts Group Revenue Of RMB125.7 Million For Year

Reuters
·
Mar 06

CARsgen-B (02171) Announces 2025 Annual Results and Proposes Amendments to Articles of Association

Bulletin Express
·
Mar 06

CARSGEN-B Reports 2025 Financial Results: Shareholder Loss Narrows Significantly

Stock News
·
Mar 06

CARsgen posts FY2025 net loss of CNY103 million, down 87%

Reuters
·
Mar 06

CARsgen Therapeutics Holdings Ltd - Expects Cash and Cash Equivalents of at Least RMB1,000 Mln at End of 2026

THOMSON REUTERS
·
Mar 06

Press Release: CARsgen Therapeutics Announces 2025 Annual Results

Dow Jones
·
Mar 06

CARsgen Therapeutics - Group's Revenue RMB125.7 Mln for Year

THOMSON REUTERS
·
Mar 06

CARSGEN-B (02171) Announces Monthly Equity Movements for February 2026

Bulletin Express
·
Mar 05